Pent-up private Wegovy demand prompts UK availability concerns
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
People in Britain who can afford to pay out of their own pocket may get easier access to Novo Nordisk’s weight-loss drug Wegovy than those seeking treatment in the country’s state-run health service, some doctors and medical experts warned on Monday.
:max_bytes(150000):strip_icc():format(jpeg)/how-to-get-dental-implants-covered-by-insurance-8580639-final-32bfbed60ccd4b7d9bd779c178672de5.png "How to Get Dental Implants Covered by Insurance")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1690944060-bfe2f518300d485e8962d425003e5c56.jpg "Ray Dalio Reveals How His Costliest Blunder Turned Into His Best Investing Lesson")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1737291285-9d716e771ad849e1b7938a09f8b1a94e.jpg "How to Find the Best Mortgage Rates")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1803777103-b9626d35c9fd4424ae7ecc3b6d58a558.jpg "Accountant Career Path and Qualifications")